对第一剂新冠疫苗的情绪反应:焦虑个体接种疫苗后焦虑和压力水平下降,而接种前焦虑水平正常的个体则上升。

Emotional Reaction to the First Dose of COVID-19 Vaccine: Postvaccination Decline in Anxiety and Stress among Anxious Individuals and Increase among Individuals with Normal Prevaccination Anxiety Levels.

作者信息

Al-Amer Rasmieh, Malak Malakeh Z, Burqan Hala Mohammad Ramadan, Stănculescu Elena, Nalubega Sylivia, Alkhamees Abdulmajeed A, Hendawy Amin Omar, Ali Amira Mohammed

机构信息

Faculty of Nursing, Isra University, Amman 11953, Jordan.

School of Nursing and Midwifery, Western Sydney University, Penrith, NSW 2751, Australia.

出版信息

J Pers Med. 2022 May 31;12(6):912. doi: 10.3390/jpm12060912.

Abstract

Although vaccination has been adopted by the WHO to limit worldwide transmission of COVID-19, people's worries about COVID-19 vaccines may suppress their desire for vaccination despite vaccine availability. This study aimed to investigate anxiety and stress symptoms among 250 Jordanians (mean age = 43.18 ± 6.34 years, 72% females) who received their first vaccine dose. The respondents completed the anxiety and stress subscales of the Depression Anxiety and Stress scale 21 (DASS-21) before and after vaccination. The respondents expressed more moderate-severe levels of stress before than after vaccination (20.8% and 13.2%, respectively). Meanwhile, 37.2% and 45.2% of the respondents expressed moderate-severe anxiety before and after vaccination, respectively. Wilcoxon signed-rank test revealed that the drop in the level of stress from before- (median (IQR) = 5 (1-8)) to after vaccination (median (IQR) = 3 (1-7)) was statistically significant (z = -3.81, = 0.001, r = 0.17) while the increase in anxiety was not. Anxiety significantly dropped postvaccination among individuals experiencing mild to severe anxiety before vaccination. Similarly, stress and anxiety significantly increased among individuals expressing normal anxiety before vaccination (z = -3.57 and -8.24, values = 0.001, r = 0.16 and 0.37, respectively). Age positively correlated with postvaccination anxiety among respondents with mild prevaccination anxiety, and it negatively correlated with the prevaccination level of stress in the normal-anxiety group. Gender, marital status, respondents' level of education, and history of COVID-19 infection had no significant correlation with anxiety or stress at either point of measurement. Overcoming their hesitancy to receive COVID-19 vaccines, individuals with normal levels of anxiety experienced a rise in their distress symptoms following immunization. On the contrary, vaccination seemed to desensitize anxious individuals. Policymakers need to formulate a population-specific plan to increase vaccine preparedness and promote psychological well-being over all during the pandemic.

摘要

尽管世界卫生组织已采用疫苗接种来限制新冠病毒在全球的传播,但尽管有疫苗可用,人们对新冠疫苗的担忧可能会抑制他们的接种意愿。本研究旨在调查250名接种了第一剂疫苗的约旦人(平均年龄 = 43.18 ± 6.34岁,72%为女性)的焦虑和压力症状。受访者在接种疫苗前后完成了抑郁焦虑压力量表21(DASS - 21)的焦虑和压力分量表。受访者在接种疫苗前表达的中度至重度压力水平高于接种后(分别为20.8%和13.2%)。同时,分别有37.2%和45.2%的受访者在接种疫苗前后表达了中度至重度焦虑。威尔科克森符号秩检验显示,压力水平从接种前(中位数(四分位距)= 5(1 - 8))降至接种后(中位数(四分位距)= 3(1 - 7))具有统计学意义(z = -3.81,p = 0.001,r = 0.17),而焦虑的增加则不具有统计学意义。接种疫苗后,接种前经历轻度至重度焦虑的个体焦虑显著下降。同样,接种前表达正常焦虑的个体压力和焦虑显著增加(z = -3.57和 -8.24,p值 = 0.001,r分别为0.16和0.37)。在接种前焦虑程度较轻的受访者中,年龄与接种后焦虑呈正相关,而在正常焦虑组中,年龄与接种前压力水平呈负相关。性别、婚姻状况、受访者的教育程度以及新冠病毒感染史在任何一个测量点与焦虑或压力均无显著相关性。焦虑水平正常的个体克服了对接种新冠疫苗的犹豫,但在免疫后其痛苦症状有所增加。相反,接种疫苗似乎使焦虑个体脱敏。政策制定者需要制定针对特定人群的计划,以提高疫苗接种准备情况,并在疫情期间全面促进心理健康。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索